前收市價 | 134.41 |
開市 | 133.78 |
買盤 | 133.73 x 100 |
賣出價 | 134.25 x 100 |
今日波幅 | 132.67 - 135.68 |
52 週波幅 | 75.22 - 189.30 |
成交量 | |
平均成交量 | 499,865 |
市值 | 7.073B |
Beta 值 (5 年,每月) | 0.98 |
市盈率 (最近 12 個月) | 88.75 |
每股盈利 (最近 12 個月) | 1.51 |
業績公佈日 | 2024年5月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 2012年11月23日 |
1 年預測目標價 | 150.03 |
The value of the “global medical device market” is expected to jump from over $500 billion last year to nearly $800 billion “by 2030.” According to the World Health Organization, “a medical device can be any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article.” Among the most exciting medical devices from an investment point of view are robotic surgical products, plastic surgery devices, glucose measuring
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Masimo's (MASI) R&D activities raise optimism about the stock.